Work

G2 checkpoint abrogators as anticancer drugs

Year: 2004

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.513.3.4

Author: Takumi Kawabe

Institution: Canbas Co., Ltd. (Japan)

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1840165714

FWCI: 14.52

Cites: 78

Cited by: 381

Related to: 10